Grant of nod to med colleges; SC rejects plea on Lodha panel

Image
Press Trust of India New Delhi
Last Updated : Sep 06 2016 | 6:22 PM IST
The Supreme Court today rejected a plea alleging that the apex court-appointed oversight panel headed by former Chief Justice of India R M Lodha had overshot MCI and Health Ministry's disapprovals and allowed several medical colleges to admit students.
A bench comprising Justices A R Dave and L Nageswara Rao trashed the contention that the panel had gone beyond its mandate of monitoring the work of Medical Council of India (MCI) and given its nod to over 100 medical colleges to start admissions without assessing their facilities.
The apex court asked Anand Rai, a doctor who had filed the PIL, to give a representation to Justice Lodha panel instead.
Rai, who claims to be a whistle blower in the Vyapam scam, today had a tough time in the packed courtroom when the bench quizzed him to ascertin his bonafide as the petitioner.
"Don't get emotional. We just want to verify certain things," the bench said when Rai broke down in the courtroom.
The bench, after perusing the plea on the last date of hearing, told Rai's counsel it wanted to ask some questions.
Senior advocate Parag Tripathi, appearing for Rai, referred to the role of his client in taking up causes of public interest including the Vyapam scam, and said he was guided by the interest to ensure quality medical education.
"My learned Brother (Justice Rao) wants to know something from Mr Rai," Justice Dave said.
As the lawyer continued, the bench interneved saying "we just wanted to know the interest of the petitioner if you (lawyer) can allow him (Rai) to come forward and answer. If he can tell us something directly, then I don't understand what is the harm."
The bench then asked him whether Rai knew about the directions passed by the oversight panel in one of its orders.
Earlier, a Constitution Bench had invoked extraordinary
powers under Article 142 of the Constitution while ordering the setting up of the three-member oversight panel to oversee the functioning of the MCI for at least a year.
The verdict had endorsed a Parliamentary Standing Committee report that medical education and profession in the country was at its "lowest ebb" and suffering from "total system failure" due to corruption.
Besides former CJI Lodha, the panel comprised Professor Shiv Sareen (Director, Institute of Liver and Biliary Sciences) and former CAG Vinod Rai.
The plea alleged that the panel had overshot MCI and the Health Ministry's disapproval of hundreds of applications made by medical colleges without conducting any "fresh" inspection or assessment.
It claimed that the panel, in August, granted recognition and allowed colleges to increase student intake and even extended the time schedule for colleges to remove deficiencies based on which MCI had recommended disapproval of their applications.
"The impugned decisions of Respondent No 3 (Lodha Committee) have the effect of compromising the standards in medical education and training in India and shall have an adverse influence on the career interests of students undertaking the undergraduate and post-graduate courses in the field of health and medicine," it said.
The petition said MCI had processed several proposals from medical colleges - varying from establishment of new medical colleges to renewal of permissions to increase in seats to grant of recognition to medicine courses for 2016-17.
Of this around 150 proposals for new undergraduate courses and 118 for super-specialty courses for 2016-17 were disapproved by the ministry on the recommendations of MCI after independent verifications had found several deficiencies in the colleges.
The petition said the Committee, on August 12 and 13, approved a "majority" of applications by medical colleges seeking renewal of permission for 2016-17, grant of recognition for undergraduate courses and increase in intake for 2016-17.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 06 2016 | 6:22 PM IST

Next Story